The U.S. Food and Drug Administration has approved Genentech’s Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
This article was originally published on MedicalXpress.com
FDA approves Susvimo for diabetic macular edema
You may also be interested in:
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
Read More:
-
At the height of the COVID-19 pandemic, firearm violence surpassed motor vehicle accidents as the leading cause of death among US children. A new study [...]
-
New Curtin University research has revealed child food insecurity in developed countries is not solely driven by poverty but is also strongly influenced by factors [...]
-
Researchers at Oregon Health & Science University’s Center for Mental Health Innovation have discovered that maternal diet during pregnancy, specifically during the third trimester, may [...]
